Zeta Global Holdings Corp (ZETA) concluded trading on Thursday at a closing price of $11.71, with 4.9 million shares of worth about $57.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -63.22% during that period and on April 10, 2025 the price saw a loss of about -9.08%. Currently the company’s common shares owned by public are about 213.18M shares, out of which, 184.36M shares are available for trading.
Stock saw a price change of -10.95% in past 5 days and over the past one month there was a price change of -19.46%. Year-to-date (YTD), ZETA shares are showing a performance of -34.91% which decreased to -2.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.93 but also hit the highest price of $38.20 during that period. The average intraday trading volume for Zeta Global Holdings Corp shares is 6.22 million. The stock is currently trading -15.05% below its 20-day simple moving average (SMA20), while that difference is down -30.65% for SMA50 and it goes to -46.34% lower than SMA200.
Zeta Global Holdings Corp (NYSE: ZETA) currently have 213.18M outstanding shares and institutions hold larger chunk of about 60.30% of that.
The stock has a current market capitalization of $2.78B and its 3Y-monthly beta is at 1.30. It has posted earnings per share of -$0.42 in the same period. It has Quick Ratio of 3.09 while making debt-to-equity ratio of 0.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZETA, volatility over the week remained 13.09% while standing at 7.49% over the month.
Stock’s fiscal year EPS is expected to rise by 29.98% while it is estimated to increase by 25.44% in next year. EPS is likely to grow at an annualized rate of 28.98% for next 5-years, compared to annual growth of -5.22% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on December 11, 2024 offering a Neutral rating for the stock and assigned a target price of $30 to it. On October 22, 2024, KeyBanc Capital Markets Initiated their recommendations, while on October 18, 2024, Barclays Downgrade their ratings for the stock with a price target of $28. Stock get an Equal-weight rating from Morgan Stanley on August 01, 2024.
